Class IITerminatedZ-0260-2020
Device recall · November 6, 2019
Dario Blood Glucose Monitoring System recall
Why: The Dario-Blood Glucose Tracker Android App versions 4.3.0-4.3.2 may experience duplicate logging of a blood glucose level reading.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dario Blood Glucose Monitoring System, Model No. 1015-05, running Android software versions 4.3.0-4.3.2
- Lots / codes
Android App Software versions 4.3.0-4.3.2
- Quantity
- 126,271 (83,141 US; 43,130 OUS)
- Company
- Labstyle Innovations, Ramat Gan
- Distribution
- Nationwide domestic distribution. Foreign distribution to Australia, Canada, UK, and Italy.
- Initiated
- August 29, 2019 · Voluntary: Firm initiated
- Classified
- October 31, 2019
- Reported
- November 6, 2019
- Ended
- May 5, 2020
- How notified
- Other
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.